Drug Database
Back to search

Poland· PL-100017084

Titlodine

A tolterodine product containing tolterodini tartras, registered in Poland by Farmak International Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.

ATC G04BD07

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTitlodineATCG04BD07REGISTER NO.PL-100017084PACKS LISTED9CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tolterodini tartrasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tolterodine is registered in 16 of 19 countries.

Countries holding a registration under ATC G04BD07 (tolterodine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search tolterodine products by name

Tolterodine · ATC G04BD07

16 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tolterodine costs, country by country.

Normalised to the WHO defined daily dose (4 mg), the median price runs from $0.70 in Italy to $1.95 in Switzerland — a ×2.8 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tolterodine · price per daily dose (4 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.95
  • ES Spain$1.16
  • IT Italy$0.70
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Tolterodini tartras
Manufacturer
Farmak International Sp. z o.o.
Country
Poland (PL)
ATC code
G04BD07
ATC class
Tolterodine
Defined daily dose
4 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 9

1 priced
  • gtin
    05909991035235
    28 szt.
    PLN 13.04
  • gtin
    05909991076702
  • gtin
    05909991076726
  • gtin
    05909991076733
  • gtin
    05909991035204
  • gtin
    05909991035259
  • gtin
    05909991035242
  • gtin
    05909991035266
  • gtin
    05909991035273

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

324 interactions on record for tolterodine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tolterodine against other medicinesHow interaction checks work

Tolterodine · interactions on record

324 records

  • 3 severe
  • 129 moderate
  • 33 minor
  • 152 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • ClotrimazoleA01AB18moderate

7 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tolterodine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tolterodine products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Detrusitol, Tolterodin Accord
  • Belgium · Detrusitol, Detrusitol Retard
  • Bulgaria · Толтеродин Акорд
  • Cyprus · Detrusitol, Tolterana
  • Germany · Detrusitol, Detrusitol Retard
  • Denmark · Detrusitol Retard, Tolterodin Rivopharm
  • Estonia · Uroflow
  • Spain · Detrusitol, Detrusitol Neo
  • Finland · Detrusitol, Detrusitol Sr
  • France · Detrusitol
  • United Kingdom (Northern Ireland) · Blerone Xl, Caristenol
  • Greece · Cinterol, Detrusitol
  • Ireland · Detrusitol, Detrusitol Sr
  • Iceland · Detrusitol Retard, Tolterodin Actavis
  • Italy · Detrusitol, Detrusitol Retard
  • Lithuania · Detrusitol, Detrusitol Sr
  • Luxembourg · Detrusitol, Detrusitol Retard
  • Latvia · Uroflow
  • Netherlands · Detrusitol, Detrusitol Sr
  • Norway · Detrusitol Sr, Tolterodine Sandoz
  • Romania · Uroflow
  • Sweden · Detrusitol, Detrusitol Sr
  • Slovenia · Detrusitol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5f02342f-ab07-4f2b-8be4-fcb2d9f3b24e
GET /v1/drugs/5f02342f-ab07-4f2b-8be4-fcb2d9f3b24e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki o przedłużonym uwalnianiu, twarde",
  "source": "urpl",
  "strength": "2 mg",
  "packaging": "05909991035204 ¦ Rp ¦ 15870\n14 kaps.\n05909991035235 ¦ Rp ¦ 16895\n28 kaps.\n05909991035259 ¦ Rp ¦ 17334\n84 kaps.\n05909991035242 ¦ Rp ¦ 18826\n30 kaps. w butelce\n05909991035266 ¦ Rp ¦ 19198\n100 kaps. w butelce\n05909991035273 ¦ Rp ¦ 19517\n200 kaps.\n05909991076702 ¦ Rp ¦ 85721\n30 kaps. w blistrach\n05909991076726 ¦ Rp ¦ 85722\n50 kaps.\n05909991076733 ¦ Rp ¦ 85723\n100 kaps. w blistrach",
  "substance": "Tolterodini tartras 2 mg",
  "common_name": "Tolterodini tartras",
  "pl_product_id": "100017084",
  "pozwolenie_nr": "20836",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about tolterodine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console